Inovio Pharmaceuticals Inc (INO) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Ben Matone -- Investor Relations J. Joseph Kim, Ph.D. -- President, Chief
Inovio Pharmaceuticals Inc (NASDAQ: INO) Q1 2020 Earnings Call Transcript
Categories
Biotechnology
Key highlights from Palatin Technologies (PTN) Q3 2020 earnings results
Palatin Technologies, Inc. (NYSE: PTN) reported a narrower loss in the third quarter of fiscal 2020 helped by lower operating expenses as
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2020 Earnings Call Transcript
Cara Therapeutics Inc. (CARA) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- Chief Executive Officer, President,
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) Q1 2020 Earnings Call Transcript
Intercept Pharmaceuticals Inc (ICPT) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Lisa DeFrancesco -- Vice President, Investor Relations Mark Pruzanski -- President, Chief
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) Q1 2020 Earnings Call Transcript
Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Christine Regan Lindenboom -- Vice President, Investor Relations and Corporate
Regeneron Pharmaceuticals (REGN) Q1 profit jumps 36%, beats estimates
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The
ImmunoGen CEO Mark Enyedy speaks on product strategy, pipeline and more
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials have been
Viking Therapeutics Inc (NASDAQ: VKTX) Q1 2020 Earnings Call Transcript
Viking Therapeutics Inc (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz -- Manager, Investor Relations Brian Lian -- President and Chief
AbbVie Inc (NYSE: ABBV) Q1 2020 Earnings Call Transcript
AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
ImmunoGen Inc. (NASDAQ: IMGN) Q1 2020 Earnings Call Transcript
ImmunoGen Inc. (IMGN) Q1 2020 earnings call dated May 01, 2020 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor Relations
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John F.
Gilead Sciences Inc. (NASDAQ: GILD) Q1 2020 Earnings Call Transcript
Gilead Sciences Inc. (GILD) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Douglas Maffei -- Investor Relations Daniel O'Day -- Chairman and Chief Executive
A visual dashboard of Amgen’s (AMGN) Q1 2020 earnings results
Amgen's (NASDAQ: AMGN) top and bottom line in the first quarter of 2020 beat analysts' estimates. The biotech firm's adjusted earnings per
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2020 Earnings Call Transcript
Vertex Pharmaceuticals Inc (VRTX) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations Reshma
What to expect from Vertex Pharmaceuticals (VRTX) Q1 2020 earnings?
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of
Lexicon Pharmaceuticals (NASDAQ: LXRX) Q1 2020 Earnings Call Transcript
Lexicon Pharmaceuticals (LXRX) Q1 2020 earnings call dated Apr. 27, 2020 Corporate Participants: Kimberly Lee -- Head of Investor Relations and Corporate Strategy Lonnel
Delay in filing Biogen’s Alzheimer’s drug leaves analysts scratching head during conference call
Late last year, Biogen (NASDAQ: BIIB) made an announcement that left investors gung-ho. The stock soared 27% after the company optimistically said
Eli Lilly & Co (NYSE: LLY) Q1 2020 Earnings Call Transcript
Eli Lilly & Co (LLY) Q1 2020 earnings call dated Apr. 23, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations David A.
Biogen Inc (NASDAQ: BIIB) Q1 2020 Earnings Call Transcript
Biogen Inc (BIIB) Q1 2020 earnings call dated Apr. 22, 2020 Corporate Participants: Joe Mara -- Vice President, Investor Relations Michel Vounatsos -- Chief Executive Officer
Infographic: Biogen (BIIB) Q1 2020 Earnings Results
Biogen Inc. (NASDAQ: BIIB) reported its financial results for the quarter ended March 31, 2020 today. Biogen posted a 1% decline in
Amarin (AMRN) exploring use of VASCEPA in COVID-19-related cardiovascular risk reduction
Shares of Amarin Corporation plc (NASDAQ: AMRN) were up 4.6% in midday trade on Tuesday, a day after the company reported preliminary